CNR2 and intestinal polyp: Furthermore, CB1 knockout, but not CB2 knockout APCmin mice (a model of colorectal cancer) have an increased risk of intestinal polyp development, a phenomenon that can be replicated by treatment with CB1 antagonists [39].